Annual Drug Patent Expirations for YONSA Yonsa is a drug marketed by Sun Pharma Global and is included in one NDA. It is available from one supplier. The generic ingredient…
The post New patent for Sun Pharma drug YONSA appeared first on DrugPatentWatc…
Annual Drug Patent Expirations for ARISTADA+INITIO+KIT Aristada Initio Kit is a drug marketed by Alkermes Inc and is included in one NDA. It is available from one supplier. The generic…
The post New patent for Alkermes Inc drug ARISTADA INITIO KIT appe…
Annual Drug Patent Expirations for IMBRUVICA Imbruvica is a drug marketed by Pharmacyclics Inc and is included in two NDAs. It is available from one supplier. There are twenty-four patents…
The post New patent for Pharmacyclics Inc drug IMBRUVICA appea…
Annual Drug Patent Expirations for BAXDELA Baxdela is a drug marketed by Melinta and is included in two NDAs. It is available from one supplier. There are thirteen patents protecting…
The post New patent for Melinta drug BAXDELA appeared first on DrugP…
Annual Drug Patent Expirations for ALIQOPA Aliqopa is a drug marketed by Bayer Healthcare and is included in one NDA. It is available from one supplier. There are three patents…
The post New patent for Bayer Healthcare drug ALIQOPA appeared first on Dr…
Annual Drug Patent Expirations for APIDRA Apidra is a drug marketed by Sanofi Aventis Us and is included in one NDA. It is available from one supplier. There are twenty-two…
The post New patent for Sanofi Aventis drug APIDRA appeared first on DrugPaten…
Annual Drug Patent Expirations for APIDRA+SOLOSTAR Apidra Solostar is a drug marketed by Sanofi Aventis Us and is included in one NDA. It is available from one supplier. There are…
The post New patent for Sanofi Aventis drug APIDRA SOLOSTAR appeared fi…
Annual Drug Patent Expirations for DEXMEDETOMIDINE+HYDROCHLORIDE Dexmedetomidine Hydrochloride is a drug marketed by Accord Hlthcare, Actavis Inc, Akorn Inc, Aurobindo Pharma Ltd, Fresenius Kabi Usa, Jiangsu Hengrui Med, Luitpold Pharms…
The post New p…
Annual Drug Patent Expirations for SOLIQUA+100%2F33 Soliqua 100/33 is a drug marketed by Sanofi-aventis Us and is included in one NDA. It is available from one supplier. There are twenty-three…
The post New patent for Sanofi-aventis Us drug SOLIQUA 100…
Annual Drug Patent Expirations for SOLIQUA+100%2F33 Soliqua 100/33 is a drug marketed by Sanofi-aventis Us and is included in one NDA. It is available from one supplier. There are twenty-three…
The post New patent for Sanofi-aventis Us drug SOLIQUA 100…